Search

everythinglearnresearchcommunity

for

Search:↓

Iron deficiency common in women, not always linked to hair loss; more research needed.

Spironolactone helps regrow hair in women with hair loss.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Finasteride may help some women with hair loss, but better options exist.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Trichoscopy is a key method for dermatologists to quickly and effectively diagnose hair and scalp conditions.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Minoxidil and finasteride combined can effectively treat hair loss.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.